NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.758
0.00 (0.03%)
Dec 20, 2024, 4:00 PM EST - Market closed
NMTC Revenue
In the fiscal year ending September 30, 2024, NeuroOne Medical Technologies had annual revenue of $3.45M with 1.33% growth. NeuroOne Medical Technologies had revenue of $272.28K in the quarter ending September 30, 2024, a decrease of -63.29%.
Revenue (ttm)
$3.45M
Revenue Growth
+1.33%
P/S Ratio
5.88
Revenue / Employee
$215,813
Employees
16
Market Cap
23.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
| Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
| Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
| Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
| Sep 30, 2020 | 1.93M | - | - |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vivos Therapeutics | 14.58M |
| Cara Therapeutics | 8.69M |
| Co-Diagnostics | 7.32M |
| Alterity Therapeutics | 2.68M |
| Longeveron | 1.85M |
| Pluri | 598.00K |
NMTC News
- 4 days ago - NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025 - GlobeNewsWire
- 11 days ago - NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead - Seeking Alpha
- 5 weeks ago - NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 7 weeks ago - NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System - GlobeNewsWire
- 3 months ago - NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference - GlobeNewsWire
- 3 months ago - NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland - GlobeNewsWire
- 3 months ago - NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire